Patent · US Active

Azaindazole compounds and methods of use

US8383630B2 · kind B2 · utility

0Cited by

12References

5Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Penglie Zhang · Foster City, US
Andrew Pennell · San Francisco, US
John J. Wright · Evansville, US
Wei Chen · Fremont, US
Manmohan Reddy Leleti · Sunnyvale, US
Yandong Li · San Jose, US
Lianfa Li · Palo Alto, US
Yuan Xu · Singapore, SG

Key dates

Filing date	Jul 1, 2010
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Jul 1, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are methods for the treatment of rheumatoid arthritis using compounds of formula Ia and Ib:or a pharmaceutically acceptable salt, hydrate or N-oxide thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.